Literature DB >> 24779523

Effects of an inpatient rehabilitation program after temporal lobe epilepsy surgery and other factors on employment 2 years after epilepsy surgery.

Rupprecht Thorbecke1, Theodor W May, Steffi Koch-Stoecker, Alois Ebner, Christian G Bien, Ulrich Specht.   

Abstract

OBJECTIVE: To evaluate the effects of a postsurgical rehabilitation program on employment status 2 years after temporal lobe epilepsy surgery in relation to other predictors.
METHODS: Employment outcome 2 years after temporal lobe resection in a group of 232 adult patients with the offer of a 3-week inpatient rehabilitation program immediately after surgery ("Reha group") was compared to a group of 119 patients who had surgery before such a rehabilitation program existed. One hundred thirty-nine (59.9%) of the Reha group patients attended the rehabilitation program. Further predictors for employment outcome were analyzed using multivariate logistic regression analysis.
RESULTS: Preoperatively, the groups did not differ significantly in variables relevant for employment, including employment rate. Two years after surgery, the rate of those not being employed had decreased in the Reha group from 38.4% to 27.6% (p < 0.001, McNemar test), and slightly increased in the control group (37.8-42.0%; n.s.), resulting in a difference of 14.4% in favor of the Reha group (p = 0.008). General unemployment rates during the two observation periods were similar. In addition to the offer of rehabilitation support ("Reha group") and preoperative employment, the following other variables were shown as significant predictors of employment post surgery in multivariate regression analysis: seizure outcome, diagnosis of a personality disorder preoperatively, and age at surgery (all, p < 0.01; Nagelkerkes R(2) = 0.59). SIGNIFICANCE: Independently from other factors, a 3-week inpatient rehabilitation program after temporal lobe epilepsy surgery seems to improve employment status 2 years after surgery. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  Employment; Epilepsy surgery; Outcome; Rehabilitation

Mesh:

Year:  2014        PMID: 24779523     DOI: 10.1111/epi.12573

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

1.  [New aspects in the field of epilepsy].

Authors:  F Rosenow; K M Klein; A Strzelczyk; H M Hamer; K Menzler; S Bauer; S Knake
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

2.  Beyond pills, machines and surgery: rehabilitation after epilepsy surgery.

Authors:  Barbara C Jobst
Journal:  Epilepsy Curr       Date:  2015 Jan-Feb       Impact factor: 7.500

3.  [Impact of early benefit assessment on patients with epilepsy in Germany: Current healthcare provision and therapeutic needs].

Authors:  A Strzelczyk; H M Hamer
Journal:  Nervenarzt       Date:  2016-04       Impact factor: 1.214

Review 4.  Current Topics in Epilepsy Surgery.

Authors:  Naotaka Usui
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-03-15       Impact factor: 1.742

5.  Prospective and longitudinal long-term employment outcomes after resective epilepsy surgery.

Authors:  Anna Edelvik; Roland Flink; Kristina Malmgren
Journal:  Neurology       Date:  2015-09-25       Impact factor: 9.910

Review 6.  Getting the best outcomes from epilepsy surgery.

Authors:  Vejay N Vakharia; John S Duncan; Juri-Alexander Witt; Christian E Elger; Richard Staba; Jerome Engel
Journal:  Ann Neurol       Date:  2018-04-10       Impact factor: 10.422

7.  Long-Term Electroclinical and Employment Follow up in Temporal Lobe Epilepsy Surgery. A Cuban Comprehensive Epilepsy Surgery Program.

Authors:  Lilia Maria Morales Chacón; Ivan Garcia Maeso; Margarita M Baez Martin; Juan E Bender Del Busto; María Eugenia García Navarro; Nelson Quintanal Cordero; Bárbara Estupiñan Díaz; Lourdes Lorigados Pedre; Ricardo Valdés Yerena; Judith Gonzalez; Randy Garbey Fernandez; Abel Sánchez Coroneux
Journal:  Behav Sci (Basel)       Date:  2018-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.